The importance of Artificial Intelligence (AI) is rapidly growing in the pharmaceutical and biotechnology industries. In particular, Celltrion's initiatives to innovate the pharmaceutical sector using AI are drawing significant attention. Today, we will explore how Celltrion is driving company-wide innovation through AI, from new drug development to manufacturing and administrative tasks.

Innovation in New Drug Development Through AI

On the 26th, Celltrion announced the integration of AI into three core business areas: new drug development, manufacturing, and administration. AI adoption is expected to expand most rapidly in new drug development. Last year, Celltrion established a dedicated AI-based new drug development team, combining bioinformatics and AI technologies to progressively apply AI in the process of discovering and validating new drug target candidates. This is anticipated to shorten the drug development timeline, which typically takes over 10 years, and enhance cost-effectiveness.

Implementing Smart Factories in Manufacturing

In its manufacturing division, Celltrion is adopting various technologies to realize a smart factory. The new raw material drug plants 4 and 5, currently under construction in Songdo, will be equipped with autonomous mobile robots, automated logistics warehouses, and intelligent robotic arms. These technologies will elevate the level of automation on the production floor, with plans to expand the application of 'Physical AI,' where AI controls equipment and robots.

• Autonomous Mobile Robots
• Automated Logistics Warehouses
• Intelligent Robotic Arms
• Collaborative Robots
• Manufacturing Execution Systems (MES)

Enhancing Efficiency in Administrative Tasks

In administrative areas, AI is already being utilized for data analysis and dashboard creation. The implementation of a chatbot within the company's electronic document management system is expected to reduce the time spent on routine tasks such as document retrieval and comparison by approximately 80-90%. The adoption of such AI technologies will enable employees to focus more on core responsibilities.

Two Approaches to AI Transformation

Celltrion's AI transformation is proceeding in two directions. The first involves business units directly creating the automation tools they need, while the second focuses on developing specialized systems at the company level. This approach allows employees not only to use AI platforms but also to implement automation solutions tailored to their specific workflows.

Celltrion explains that the AI technologies introduced starting this year are contributing to expanding the scope of work automation and increasing efficiency. Through this AI-driven value chain, the company aims to leap forward as a global comprehensive pharmaceutical company.